Lawyers For Zantac Lawsuit
Zantac (ranitidine) lawsuits make the claim that the antacid and antihistamine Zantac can be contaminated with the cancer-causing organic compound N-nitrosodimethylamine (NDMA).
The attorneys at our law firm are accepting claims from clients who have taken Zantac and have been diagnosed with any of the following cancers:
We have been processing lawsuits against drug companies for more than a quarter century. You can find our law firm listed in Best Lawyers and Super Lawyers.
In mid-September 2019, the FDA reported the discovery of dangerous cancer-causing N-nitrosodimethylamine (NDMA) in the over-the-counterand prescription heartburn medication Zantac (ranitidine).
In April 2020, the U.S. Food and Drug Administration announced that all Zantac brand heartburn medication should be pulled from the shelves immediately due to potential contamination by dangerous NDMA.
The initial Zantac heartburn medication legal claimwas filed in the state of California in 2019. In that court case, the injured party accused Sanofi and Boerhringer Ingelheim of producing, marketing and ultimately selling an acid reducing medication they realistically should have identified as being contaminated with the cancer-causing N-nitrosodimethylamine.
The cause of contamination by NDMA remains under a point of contention. However, while in the middle of the time frame whenBoerhinger Ingelheim and Sanofi were manufacturing and marketing Zantac, research indicated an easily identifiable link between the key ingredient in the medication and NDMA. The problem is that, when the active ingredient in Zantac is introduced to into the human body or exposed, it initiates a chemical reaction that results in the formation of N-nitrosodimethylamine.
Even with the abundance of available information, the drug manufacturer made the decision not to explain the risk to its users or the government.